Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|May 18, 2005
The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolitesSusan Pratt, Robert L Shepard, Ramani A Kandasamy, et al.
The American Journal of Physiology|March 1, 1992
Basolateral 3-O-methylglucose transport by cultured kidney (LLC-PK1) epithelial cellsJ M Mullin, L M Kofeldt, L M Russo, et al.
Pharmaceutical Research|October 1, 1994
Mechanism and kinetics of transcellular transport of a new beta-lactam antibiotic loracarbef across an intestinal epithelial membrane model system (Caco-2)M Hu, J Chen, Y Zhu, et al.
Journal of Drug Targeting|January 1, 1995
Peptide transporter function and prolidase activities in Caco-2 cells: a lack of coordinated expressionM Hu, L Zheng, J Chen, et al.
Molecular Cancer Therapeutics|January 9, 2003
Identification and characterization of the canine multidrug resistance-associated proteinLiandong Ma, Susan E Pratt, Jin Cao, et al.
Pharmaceutical Research|August 1, 1995
Mechanisms of transport of quinapril in Caco-2 cell monolayers: comparison with cephalexinM Hu, L Zheng, J Chen, et al.
Molecular Cancer Therapeutics|March 27, 2003
Cloning and functional characterization of the multidrug resistance-associated protein (MRP1/ABCC1) from the cynomolgus monkeyNathalie Godinot, Philip W Iversen, Linda Tabas, et al.
Biochemical Pharmacology|September 29, 1998
Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoproteinR L Shepard, M A Winter, S C Hsaio, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cellsN J Snyder, L B Tabas, D M Berry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2013
Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cellsSusan E Pratt, Sara Durland-Busbice, Robert L Shepard, et al.
Pageof 6